New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
12:13 EDTELOSSyneron Medical recommend following FDA clearance at Maxim
Maxim recommends investors continue buying shares of Syneron Medical following the FDA clearance of UltraShape. Maxim says UltraShape expands the base of body shaping treatments that physicians may use with complimentary Syneron systems and it keeps a Buy rating on the stock with a $16 price target.
News For ELOS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
07:13 EDTELOSCanaccord to hold a forum
Subscribe for More Information
November 12, 2014
06:19 EDTELOSSyneron Medical reports Q3 EPS 3c, consensus 3c
Reports Q3 revenue $60.3M, consensus $58.32M. Neutralized for the foreign currency impact, Q3 non-GAAP earnings per share would have been 5c.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use